Target intelligence / Profile preview

Cellular iron handling pathways

Molecular classification
Transporter, Receptor, Enzyme, Other
01

Overview

Cellular iron handling pathways encompass the coordinated molecular mechanisms responsible for the uptake, storage, utilization, and export of iron to maintain cellular homeostasis [1, 9]. Key components include Transferrin Receptor 1 (TfR1) for iron entry via endocytosis, Ferritin for intracellular storage, and Ferroportin (FPN) for iron export into the circulation [3, 4]. These pathways are tightly regulated by the Hepcidin-Ferroportin axis and the Iron Regulatory Protein (IRP)/Iron-Responsive Element (IRE) system, which sense intracellular iron levels and modulate the translation of key transporters and storage proteins [8, 11]. Dysregulation of these pathways is a hallmark of various diseases; for instance, cancer cells often upregulate iron uptake (e.g., TfR1) and downregulate export to support rapid proliferation, while iron overload or deficiency leads to conditions like hemochromatosis or anemia [1, 5]. Therapeutic strategies targeting these pathways include iron chelators to deplete the labile iron pool, hepcidin mimetics to restrict iron availability, and ferroptosis inducers to trigger iron-dependent cell death in tumors [2, 10]. Monitoring these pathways involves biomarkers such as serum ferritin, transferrin saturation, and hepcidin levels to assess systemic and cellular iron status [3, 14].

Other names
Cellular iron metabolismIron homeostasis pathwaysIntracellular iron traffickingIron metabolic pathways
02

Mechanism of action

Iron chelation, hepcidin-mediated degradation of ferroportin, inhibition of transferrin receptor-mediated endocytosis, and induction of ferroptosis.

03

Biological functions

Iron homeostasisCellular respirationDNA synthesisOxygen transportCell death
04

Disease associations

CancerAnemiaNeurodegenerative diseaseCardiovascular diseaseInfection
05

Safety considerations

Oxidative stress and tissue damageIron deficiency anemiaIncreased susceptibility to siderophilic infectionsOff-target chelation of other essential metalsGastrointestinal toxicity from oral iron
06

Interacting drugs

Deferoxamine

8 more in the full profile.

07

Biomarkers

Serum ferritinTransferrin saturation (TSAT)HepcidinSoluble transferrin receptor (sTfR)Labile iron pool (LIP)

Beyond the preview

Go deeper on Cellular iron handling pathways.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cellular iron handling pathways.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call